Human T-lymphotropic virus type 1–associated myelopathy/tropical spastic paraparesis: Viral load and muscle tone are correlated

References

• de Thé G, Bomford R. An HTLV-1 vaccine: why, how, for whom?. AIDS Res Hum Retroviruses 1993; 9: 381–386, [CSA]
   PubMed Web of Science ®Google Scholar
• Haas B M, Bergstrom E, Jamous A, Bennie A. The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury. Spinal Cord 1996; 34: 560–564, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kaplan J E, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz R F, Janssen R S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-1. J Acquir Immune Defic Syndr 1990; 3: 1096–1101, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lehmann J F, Price R, deLateur B J, Hinderer S, Traynor C. Spasticity: quantitative measurements as a basis for assessing effectiveness of therapeutic intervention. Arch Phys Med Rehabil 1989; 70: 6–15, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Leon S F, Costa C M, Gaffga N. Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta-analysis on 2811 patients. Arq Neuropsiquiatr 1997; 55: 530–535, [CSA]
   PubMedGoogle Scholar
• Lezin A, Olindo S, Oliere S, Varrin-Doyer M, Marlin R, Cabre P, Smadja D, Cesaire R. Human T lymphotropic virus type 1 (HTLV-1) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-1-associated myelopathy/tropical spastic paraparesis?. J Infect Dis 2005; 191: 1830–1834, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Maloney E M, Cleghorn F R, Morgan O S, Rodgers-Johnson P, Cranston B, Jack N, Blattner W A, Bartholomew C, Manns A. Incidence of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 167–170, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M. HTLV-1 proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J NeuroVirol 2001; 7: 228–234, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Murphy E L, Fridey J, Smith J W, Engstrom J, Sacher R A, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, Kaplan J, Khabbaz R, Nemo G. HTLV-associated myelopathy in a cohort of HTLV-1 and HTLV-2-infected blood donors. The REDS investigators. Neurology 1997; 48: 315–320, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Nagai M, Kubota R, Greten T F, Schneck J P, Leist T P, Jacobson S. Increased activated human T cell lymphotropic virus type 1 (HTLV-1) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-1 provirus load. J Infect Dis 2001; 183: 197–205, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham C R, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 1998; 4: 586–593, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Osame M. [The recent advances of HAM/TSP research]. Rinsho Shinkeigaku 1999; 39: 1200–1202, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Price R, Bjornson K F, Lehmann J F, McLaughlin J F, Hays R M. Quantitative measurement of spasticity in children with cerebral palsy. Dev Med Child Neurol 1991; 33: 585–595, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Roman G C, Roman L N. Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome. J Neurol Sci 1988; 87: 121–138, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Vernant J C, Maurs L, Gessain A, Barin F, Gout O, Delaporte J M, Sanhadji K, Buisson G, de Thé G. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type 1: a clinical and seroepidemiological study of 25 cases. Ann Neurol 1987; 21: 123–130, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Zunt J R, Alarcon J O, Montano S, Longstreth W T, Jr, Price R, Holmes K K. Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type 1 infection. Neurology 1999; 53: 386–390, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zunt J R, Montano S M, Alarcon J O, Longstreth W T, Jr, Price R, Holmes K K. Quantitative assessment of spasticity in human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis. J NeuroVirol 2005; 11: 70–73, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar